Translational mini-review series on the immunogenetics of gut disease: Immunogenetics of coeliac disease

Clinical and Experimental Immunology

Volumn 153, Issue 2, 2008, Pages 162-173

  Dubois, P C ^a   Van Heel, D A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Autoimmune; Coeliac; Genetics; Genome wide association; Immunogenetics

Indexed keywords

EPITOPE; GLUTEN; HLA B8 ANTIGEN; HLA DQ2 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR3 ANTIGEN; HLA DR5 ANTIGEN; HLA DR7 ANTIGEN; INTERLEUKIN 12P35; INTERLEUKIN 2; INTERLEUKIN 21;

AUTOIMMUNE DISEASE; CELIAC DISEASE; CELLULAR IMMUNITY; CHROMOSOME 3P; DISEASE PREDISPOSITION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE;

ANTIGENS; AUTOIMMUNITY; CELIAC DISEASE; FORECASTING; GASTROINTESTINAL TRACT; GENETIC PREDISPOSITION TO DISEASE; GLUTEN; HUMANS; IMMUNITY, NATURAL; IMMUNOGENETICS;

EID: 47249136580     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03704.x     Document Type: Short Survey

References (118)

1. van Heel DA, West J. Recent advances in coeliac disease. Gut 2006 55:1037 46.
2. van Heel DA, Franke L, Hunt KA et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007 39:827 9.
3. Hunt KA, Zhernakova A, Turner G et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008.
4. West J, Logan RF, Hill PG et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003 52:960 5.
5. Accomando S, Cataldo F. The global village of celiac disease. Dig Liver Dis 2004 36:492 8.
6. Freeman HJ. Biopsy-defined adult celiac disease in Asian-Canadians. Can J Gastroenterol 2003 17:433 6.
7. Bonamico M, Mariani P, Triglione P et al. Celiac disease in two sisters with a mother from Cape Verde Island, Africa: a clinical and genetic study. J Pediatr Gastroenterol Nutr 1994 18:96 9.
8. Fasano A, Berti I, Gerarduzzi T et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003 163:286 92.
9. Cataldo F, Lio D, Simpore J, Musumeci S. Consumption of wheat foodstuffs not a risk for celiac disease occurrence in Burkina Faso. J Pediatr Gastroenterol Nutr 2002 35:233 4.
10. Catassi C, Doloretta Macis M, Ratsch IM, De Virgiliis S, Cucca F. The distribution of DQ genes in the Saharawi population provides only a partial explanation for the high celiac disease prevalence. Tissue Antigens 2001 58:402 6.
11. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001 120:636 51.
12. Weile B, Cavell B, Nivenius K, Krasilnikoff PA. Striking differences in the incidence of childhood celiac disease between Denmark and Sweden: a plausible explanation. J Pediatr Gastroenterol Nutr 1995 21:64 8.
13. Mitt K, Uibo O. Low cereal intake in Estonian infants: the possible explanation for the low frequency of coeliac disease in Estonia. Eur J Clin Nutr 1998 52:85 8.
14. Lohi S, Mustalahti K, Kaukinen K et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007 26:1217 25.
15. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000 355:873 6.
16. Ivarsson A, Hernell O, Stenlund H, Persson LA. Breast-feeding protects against celiac disease. Am J Clin Nutr 2002 75:914 21.
17. Ientile R, Caccamo D, Griffin M. Tissue transglutaminase and the stress response. Amino Acids 2007 33:385 94.
18. Ivarsson A, Hernell O, Nystrom L, Persson LA. Children born in the summer have increased risk for coeliac disease. J Epidemiol Commun Health 2003 57:36 9.
19. Ivarsson A. The Swedish epidemic of coeliac disease explored using an epidemiological approach - some lessons to be learnt. Best Pract Res 2005 19:425 40.
20. Sandberg-Bennich S, Dahlquist G, Kallen B. Coeliac disease is associated with intrauterine growth and neonatal infections. Acta Paediatr 2002 91:30 3.
21. Stene LC, Honeyman MC, Hoffenberg EJ et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006 101:2333 40.
22. Matysiak-Budnik T, Malamut G, de Serre NP et al. Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut 2007 56:1379 86.
23. Simell S, Hoppu S, Hekkala A et al. Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study. Am J Gastroenterol 2007 102:2026 35.
24. Greco L, Romino R, Coto I et al. The first large population based twin study of coeliac disease. Gut 2002 50:624 8.
25. Petronzelli F, Bonamico M, Ferrante P et al. Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet 1997 61:307 17.
26. Bevan S, Popat S, Braegger CP et al. Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet 1999 36:687 90.
27. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987 40:1 14.
28. Lewis CM, Whitwell SC, Forbes A, Sanderson J, Mathew CG, Marteau TM. Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease. J Med Genet 2007 44:689 94.
29. Robinson J, Waller MJ, Parham P et al. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 2003 31:311 14.
30. Falchuk ZM, Rogentine GN, Strober W. Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy. J Clin Invest 1972 51:1602 5.
31. Keuning JJ, Pena AS, van Leeuwen A, van Hooff JP, van Rood JJ. HLA-DW3 associated with coeliac disease. Lancet 1976 1:506 8.
32. Price P, Witt C, Allcock R et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999 167:257 74.
33. Tosi R, Vismara D, Tanigaki N et al. Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol 1983 28:395 404.
34. van Heel DA, Hunt K, Greco L, Wijmenga C. Genetics in coeliac disease. Best Pract Res 2005 19:323 39.
35. Vader W, Stepniak D, Kooy Y et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 2003 100:12390 5.
36. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000 18:53 81.
37. Louka AS, Nilsson S, Olsson M et al. HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens 2002 60:147 54.
38. van Belzen MJ, Koeleman BP, Crusius JB et al. Defining the contribution of the HLA region to cis DQ2-positive coeliac disease patients. Genes Immun 2004 5:215 20.
39. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989 169:345 50.
40. Spurkland A, Sollid LM, Polanco I, Vartdal F, Thorsby E. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non DR3 or non-DR5/7. Hum Immunol 1992 35:188 92.
41. Karell K, Louka AS, Moodie SJ et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003 64:469 77.
42. Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 2003 61:105 17.
43. Louka AS, Moodie SJ, Karell K et al. A collaborative European search for non-DQA1*05-DQB1*02 celiac disease loci on HLA-DR3 haplotypes: analysis of transmission from homozygous parents. Hum Immunol 2003 64:350 8.
44. Greco L, Babron MC, Corazza GR et al. Existence of a genetic risk factor on chromosome 5q in Italian coeliac disease families. Ann Hum Genet 2001 65:35 41.
45. Greco L, Corazza G, Babron MC et al. Genome search in celiac disease. Am J Hum Genet 1998 62:669 75.
46. Van Belzen MJ, Meijer JW, Sandkuijl LA et al. A major non-HLA locus in celiac disease maps to chromosome 19. Gastroenterology 2003 125:1032 41.
47. Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 1998 43:187 9.
48. Monsuur AJ, de Bakker PI, Alizadeh BZ et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005 37:1341 4.
49. Hunt KA, Monsuur AJ, McArdle WL et al. Lack of association of MYO9B genetic variants with coeliac disease in a British cohort. Gut 2006 55:969 72.
50. Amundsen SS, Monsuur AJ, Wapenaar MC et al. Association analysis of MYO9B gene polymorphisms with celiac disease in a Swedish/Norwegian cohort. Hum Immunol 2006 67:341 5.
51. Sanchez E, Alizadeh BZ, Valdigem G et al. MYO9B gene polymorphisms are associated with autoimmune diseases in Spanish population. Hum Immunol 2007 68:610 15.
52. Anand BS, Piris J, Jerrome DW, Offord RE, Truelove SC. The timing of histological damage following a single challenge with gluten in treated coeliac disease. Q J Med 1981 50:83 94.
53. Nilsen EM, Jahnsen FL, Lundin KE et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998 115:551 63.
54. Monteleone I, Monteleone G, Vecchio Blanco DG et al. Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa. Gut 2004 53:1090 5.
55. Di Sabatino A, Pickard KM, Gordon JN et al. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology 2007 133:1175 87.
56. Salvati VM, MacDonald TT, Bajaj-Elliott M et al. Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut 2002 50:186 90.
57. Monteleone G, Pender SL, Alstead E et al. Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 2001 48:425 9.
58. Leon AJ, Garrote JA, Blanco-Quiros A et al. Interleukin 18 maintains a long-standing inflammation in coeliac disease patients. Clin Exp Immunol 2006 146:479 85.
59. Raki M, Tollefsen S, Molberg O, Lundin KE, Sollid LM, Jahnsen FL. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology 2006 131:428 38.
60. Lundin KE, Scott H, Hansen T et al. Gliadin-specific, HLA-DQ (alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993 178:187 96.
61. Lundin KE, Scott H, Fausa O, Thorsby E, Sollid LM. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol 1994 41:285 91.
62. Arentz-Hansen H, Korner R, Molberg O et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000 191:603 12.
63. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000 6:337 42.
64. Anderson RP, van Heel DA, Tye-Din JA et al. T cells in peripheral blood after gluten challenge in coeliac disease. Gut 2005 54:1217 23.
65. Arentz-Hansen H, McAdam SN, Molberg O et al. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 2002 123:803 9.
66. Vader W, Kooy Y, Van Veelen P et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 2002 122:1729 37.
67. Sjostrom H, Lundin KE, Molberg O et al. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol 1998 48:111 15.
68. Tollefsen S, Arentz-Hansen H, Fleckenstein B et al. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest 2006 116:2226 36.
69. Vartdal F, Johansen BH, Friede T et al. The peptide binding motif of the disease associated HLA-DQ (alpha 1*0501, beta 1*0201) molecule. Eur J Immunol 1996 26:2764 72.
70. van de Wal Y, Kooy YM, Drijfhout JW et al. alpha 1*0201, beta 1*0202) molecule. Immunogenetics 1997 46:484 92.
71. Godkin A, Friede T, Davenport M et al. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Int Immunol 1997 9:905 11.
72. Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci USA 2004 101:4175 9.
73. van de Wal Y, Kooy Y, van Veelen P et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998 161:1585 8.
74. Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997 3:797 801.
75. Molberg O, McAdam SN, Korner R et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998 4:713 17.
76. Fleckenstein B, Molberg O, Qiao SW et al. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J Biol Chem 2002 277:34109 16.
77. Zanoni G, Navone R, Lunardi C et al. In celiac disease, a subset of autoantibodies against transglutaminase binds Toll-like receptor 4 and induces activation of monocytes. PLoS Med 2006 3:e358.
78. Myrsky E, Kaukinen K, Syrjanen M, Korponay-Szabo IR, Maki M, Lindfors K. Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis. Clin Exp Immunol 2008 152:111 19.
79. Korponay-Szabo IR, Halttunen T, Szalai Z et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004 53:641 8.
80. Hadjivassiliou M, Maki M, Sanders DS et al. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology 2006 66:373 7.
81. Hausch F, Shan L, Santiago NA, Gray GM, Khosla C. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol 2002 283:G996 G1003.
82. Sturgess R, Day P, Ellis HJ et al. Wheat peptide challenge in coeliac disease. Lancet 1994 343:758 61.
83. Fraser JS, Engel W, Ellis HJ et al. Coeliac disease: in vivo toxicity of the putative immunodominant epitope. Gut 2003 52:1698 702.
84. Maiuri L, Picarelli A, Boirivant M et al. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology 1996 110:1368 78.
85. Maiuri L, Ciacci C, Ricciardelli I et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003 362:30 7.
86. Di Sabatino A, Ciccocioppo R, Cupelli F et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 2006 55:469 77.
87. Mention JJ, Ben Ahmed M, Begue B et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003 125:730 45.
88. Jabri B, de Serre NP, Cellier C et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 2000 118:867 79.
89. Meresse B, Curran SA, Ciszewski C et al. Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med 2006 203:1343 55.
90. Hue S, Mention JJ, Monteiro RC et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004 21:367 77.
91. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev 2005 6:95 108.
92. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007 447:661 78.
93. Gorlov IP, Gorlova OY, Sunyaev SR, Spitz MR, Amos CI. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet 2008 82:100 12.
94. Korbel JO, Urban AE, Affourtit JP et al. Paired-end mapping reveals extensive structural variation in the human genome. Science 2007 318:420 6.
95. Estivill X, Armengol L. Copy number variants and common disorders: filling the gaps and exploring complexity in genome-wide association studies. PLoS Genet 2007 3:1787 99.
96. Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev 2006 6:595 601.
97. Lenardo MJ. Fas and the art of lymphocyte maintenance. J Exp Med 1996 183:721 4.
98. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005 6:1142 51.
99. Maloy KJ, Powrie F. Fueling regulation: IL-2 keeps CD4+ Treg cells fit. Nat Immunol 2005 6:1071 2.
100. Yamanouchi J, Rainbow D, Serra P et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 2007 39:329 37.
101. Fina D, Sarra M, Caruso R et al. Interleukin-21 contributes to the mucosal T helper cell type 1 response in celiac disease. Gut 2007 online early.
102. Leonard WJ, Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev 2005 5:688 98.
103. Mathew CG. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat Rev Genet 2007 9:9 14.
104. Todd JA, Walker NM, Cooper JD et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007 39:857 64.
105. Pennington DJ, Silva-Santos B, Shires J et al. The inter-relatedness and interdependence of mouse T cell receptor gammadelta+ and alphabeta+ cells. Nat Immunol 2003 4:991 8.
106. Han SB, Moratz C, Huang NN et al. Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. Immunity 2005 22:343 54.
107. Li Y, He X, Schembri-King J, Jakes S, Hayashi J. Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation. J Immunol 2000 164:5199 206.
108. Velazquez L, Cheng AM, Fleming HE et al. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med 2002 195:1599 611.
109. Lemmon MA. Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol 2008 9:99 111.
110. Lindvall JM, Blomberg KE, Valiaho J et al. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol Rev 2005 203:200 15.
111. Carpten JD, Faber AL, Horn C et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 2007 448:439 44.
112. Mao M, Biery MC, Kobayashi SV et al. T lymphocyte activation gene identification by coregulated expression on DNA microarrays. Genomics 2004 83:989 99.
113. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002 346:180 8.
114. Zhernakova A, Alizadeh BZ, Bevova M et al. Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet 2007 81:1284 8.
115. Liu Y, Helms C, Liao W et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008 4:e1000041.
116. Ballotti S, de Martino M. Rotavirus infections and development of type 1 diabetes: an evasive conundrum. J Pediatr Gastroenterol Nutr 2007 45:147 56.
117. Altshuler D, Hirschhorn JN, Klannemark M et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000 26:76 80.
118. van Dam RM, Hoebee B, Seidell JC, Schaap MM, de Bruin TW, Feskens EJ. Common variants in the ATP-sensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies and meta-analyses. Diabet Med 2005 22:590 8.